Pre- and post-prandial plasma ghrelin levels do not correlate with satiety or failure to achieve a successful outcome after Roux-en-Y gastric bypass

Obes Surg. 2005 Aug;15(7):1017-23. doi: 10.1381/0960892054621071.

Abstract

Background: We tested the hypothesis that the amount of weight lost after Roux-en-Y gastric bypass (RYGBP) correlates with plasma ghrelin levels.

Methods: 36 morbidly obese patients were studied 3 years after RYGBP (6 men, 30 women) with mean initial BMI 51 kg/m2 and 8 healthy controls (2 men, 6 women) with mean BMI 25 kg/m2. Subjects consumed a light breakfast, and the first blood sample was drawn at 1200 hrs immediately before lunch and the second sample at 1400 hrs. Satiety was assessed using a Visual Analog Scale (VAS). Patients were stratified as success (current BMI <35) or failures (current BMI > or =35).

Results: Plasma ghrelin levels were significantly lower in patients after RYGBP (269 +/- 66 pcg/ml) compared with lean controls (616 +/- 112 pcg/ml, P<0.001). Ghrelin levels pre or post meals were not different between patients who had a successful weight loss (preoperative BMI 47, current BMI 29, 72% EWL) or those who achieved a less then ideal weight loss (preoperative BMI 48, current BMI 41, 29% EWL). There was no correlation between any of the VAS scores and plasma ghrelin. There was a strong inverse correlation between pre-prandial ghrelin levels and the preoperative or current BMI.

Conclusion: Failure to lose weight after RYGBP does not correlate with pre- or post-prandial ghrelin plasma levels. Ghrelin levels were inversely proportional to BMI and did not correlate with satiety. These data do not support a role for higher plasma ghrelin levels for inadequate weight loss after RYGBP.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Anastomosis, Roux-en-Y
  • Cohort Studies
  • Female
  • Gastric Bypass / methods*
  • Ghrelin
  • Humans
  • Male
  • Obesity, Morbid / blood
  • Obesity, Morbid / physiopathology
  • Obesity, Morbid / surgery*
  • Peptide Hormones / blood*
  • Satiation / physiology*
  • Treatment Outcome
  • Weight Loss / physiology*

Substances

  • Ghrelin
  • Peptide Hormones